Diagnostic and Laboratory Testing in Psychiatry |
From inside the book
Results 1-5 of 91
Page
The sensitivity ( true positives ) , specificity ( exclusion of false positives ) , and confidence level ... the research and clinical levels , and have produced succinct and practical summaries of virtually every clinical and ...
The sensitivity ( true positives ) , specificity ( exclusion of false positives ) , and confidence level ... the research and clinical levels , and have produced succinct and practical summaries of virtually every clinical and ...
Page
Other psychiatrists use antidepressant dose - prediction tests , blood levels of antidepressants , blood levels of antipsychotics , dopamine radioreceptor binding as an index of total dopamine receptor blockade in antipsychotic ...
Other psychiatrists use antidepressant dose - prediction tests , blood levels of antidepressants , blood levels of antipsychotics , dopamine radioreceptor binding as an index of total dopamine receptor blockade in antipsychotic ...
Page
The confidence level describes the likelihood that an abnormal laboratory result in a given population will identify a true positive patient . For a test to be useful in laboratory medicine , neither 100 % sensitivity ...
The confidence level describes the likelihood that an abnormal laboratory result in a given population will identify a true positive patient . For a test to be useful in laboratory medicine , neither 100 % sensitivity ...
Page 4
Tryptophan Levels and Competing Amino Acids 10. Summary References 77 78 78 79 79 80 81 81 82 82 83 83 84 87 8. Platelet and Trait Markers Mark S. Gold , M.D. , and H. Rowland Pearsall , M.D. 1. Introduction .... 2. Platelets ... 2.1 .
Tryptophan Levels and Competing Amino Acids 10. Summary References 77 78 78 79 79 80 81 81 82 82 83 83 84 87 8. Platelet and Trait Markers Mark S. Gold , M.D. , and H. Rowland Pearsall , M.D. 1. Introduction .... 2. Platelets ... 2.1 .
Page 5
Therapeutic Drug Level Monitoring in Psychiatry ... 131 Sheldon H. Preskorn , M.D. , Mark S. Gold , M.D. , and Irl Extein ... Plasma Levels of Tricyclic Antidepressants 139 9. Pharmacokinetics of Tricyclic Antidepressants 139 9.1 .
Therapeutic Drug Level Monitoring in Psychiatry ... 131 Sheldon H. Preskorn , M.D. , Mark S. Gold , M.D. , and Irl Extein ... Plasma Levels of Tricyclic Antidepressants 139 9. Pharmacokinetics of Tricyclic Antidepressants 139 9.1 .
What people are saying - Write a review
We haven't found any reviews in the usual places.
Contents
I | 9 |
III | 9 |
IV | 9 |
V | 9 |
VI | 9 |
VII | 9 |
VIII | 9 |
IX | 10 |
CXXVIII | 124 |
CXXIX | 129 |
CXXXI | 130 |
CXXXII | 131 |
CXXXIV | 132 |
CXXXV | 134 |
CXXXVI | 135 |
CXXXVII | 136 |
X | 11 |
XIII | 12 |
XVI | 13 |
XIX | 14 |
XXII | 15 |
XXVII | 16 |
XXIX | 17 |
XXX | 18 |
XXXI | 25 |
XXXIII | 26 |
XXXIV | 29 |
XXXVII | 30 |
XXXVIII | 36 |
XXXIX | 37 |
XL | 38 |
XLII | 39 |
XLIII | 40 |
XLV | 41 |
XLVI | 42 |
XLVII | 43 |
XLVIII | 45 |
L | 46 |
LI | 47 |
LIV | 48 |
LVI | 49 |
LVII | 50 |
LVIII | 51 |
LXI | 53 |
LXIII | 54 |
LXIV | 57 |
LXV | 58 |
LXVI | 59 |
LXVII | 60 |
LXVIII | 61 |
LXIX | 62 |
LXXI | 63 |
LXXIII | 64 |
LXXIV | 66 |
LXXVI | 68 |
LXXVIII | 69 |
LXXX | 70 |
LXXXII | 71 |
LXXXIII | 72 |
LXXXIV | 75 |
LXXXVII | 77 |
LXXXVIII | 78 |
LXXXIX | 79 |
XC | 80 |
XCII | 81 |
XCIV | 82 |
XCV | 85 |
XCVI | 86 |
XCVII | 87 |
XCVIII | 88 |
C | 90 |
CII | 91 |
CIII | 92 |
CIV | 93 |
CV | 97 |
CVI | 98 |
CVII | 99 |
CVIII | 101 |
CIX | 103 |
CX | 104 |
CXI | 105 |
CXIV | 106 |
CXV | 107 |
CXVI | 108 |
CXVII | 109 |
CXVIII | 110 |
CXX | 111 |
CXXI | 113 |
CXXII | 115 |
CXXIII | 116 |
CXXIV | 120 |
CXXV | 121 |
CXXVI | 122 |
CXXVII | 123 |
CXXXIX | 137 |
CXL | 138 |
CXLI | 139 |
CXLII | 140 |
CXLIII | 141 |
CXLIV | 142 |
CXLV | 143 |
CXLVI | 144 |
CXLVII | 145 |
CXLVIII | 147 |
CXLIX | 148 |
CLI | 149 |
CLII | 150 |
CLIII | 153 |
CLIV | 154 |
CLV | 155 |
CLVII | 156 |
CLVIII | 157 |
CLIX | 159 |
CLX | 160 |
CLXI | 161 |
CLXII | 162 |
CLXIII | 164 |
CLXIV | 167 |
CLXV | 169 |
CLXVI | 171 |
CLXVII | 172 |
CLXVIII | 174 |
CLXIX | 177 |
CLXX | 179 |
CLXXI | 180 |
CLXXII | 183 |
CLXXIII | 185 |
CLXXV | 186 |
CLXXVI | 189 |
CLXXVII | 193 |
CLXXIX | 194 |
CLXXX | 195 |
CLXXXI | 196 |
CLXXXIII | 197 |
CLXXXIV | 198 |
CLXXXVI | 199 |
CLXXXVIII | 200 |
CLXXXIX | 201 |
CXCI | 202 |
CXCII | 203 |
CXCIV | 204 |
CXCVII | 205 |
CXCVIII | 208 |
CC | 209 |
CCI | 213 |
CCII | 218 |
CCIII | 219 |
CCIV | 224 |
CCV | 230 |
233 | |
CCVII | 235 |
CCVIII | 237 |
CCIX | 238 |
CCX | 239 |
CCXI | 240 |
CCXII | 242 |
CCXIII | 243 |
247 | |
CCXV | 249 |
CCXVI | 250 |
CCXVII | 251 |
CCXVIII | 252 |
CCXIX | 253 |
CCXX | 254 |
259 | |
CCXXII | 261 |
CCXXIV | 263 |
CCXXV | 264 |
CCXXVI | 266 |
CCXXVII | 267 |
269 | |
Common terms and phrases
abnormal abuse activity addition affective disorders alcohol anorexia antidepressant anxiety Arch Gen Psychiatry assessment associated behavior bipolar blood body brain cause central changes chronic Clin clinical complex concentration correlate cortisol criteria decreased deficiency dementia depressed patients detection determined dexamethasone diagnosis differential disease dose drug endogenous et al evaluation examination factors findings function glucose Gold growth half-life hormone Hospital hypothyroidism imaging important improve increased indicated laboratory lead levels lithium major depression mania measure mental metabolites MHPG mood neurological normal occur organic panic patterns physical plasma platelet positive possible present produce psychiatric psychosis psychotic recent relationship release reported response sample scales scan schizophrenia screen secretion sensitive serotonin serum severe significant signs specific stimulation studies substance suggested suppression symptoms syndrome Table thyroid tion treated treatment urine usually withdrawal York